Skip to main content

Table 1 Demographic, clinical, and laboratory characteristics of patients

From: Prevalence and prognostic value of plasma glucose abnormalities among full-term and late-preterm neonates with sepsis

Characteristic Survivors (n = 135 ) Non-survivors (n = 39 ) All patients (n = 174) P value
Postnatal age, days 7 (1–27) 11 (1–27) 8 (1–27) 0.001*
Female sex 62 (45.9%) 16 (41%) 78 (45%) 0.59
Weight, kg 2.73 ± 0.58 2.46 ± 0.71 2.66 ± 0.62 0.022*
Gestational age, week 38 (35–40) 37 (35–42) 37.5 (35–42) 0.25
Preterm 34 (25.2%) 15 (38.5%) 49 (28.2%) 0.1
Full term 101 (74.8%) 24 (61.5%) 125 (71.8%)
Cesarean delivery 108 (80%) 33 (84.6%) 141 (81%) 0.52
Early-onset sepsis 37 (27.4%) 8 (20.5%) 45 (25.8%) 0.39
Late-onset sepsis 98 (72.6%) 31 (79.5%) 129 (74.1%)
Proven sepsis 47 (34.8%) 26 (66.7%) 73 (42%) < 0.001*
Possible sepsis 88 (65.2%) 13 (33.3) 101 (58%)
Invasive mechanical ventilation 76 (56.3%) 35 (89.7%) 111 (63.8%) < 0.001*
Type of organism 0.48
 Gram positive 14 (10.4%) 5 (12.8%) 19 (10.9%)
 Gram negative 29 (21.5%) 17 (43.6%) 46 (26.4%)
Candida 4 (3%) 4 (10.3%) 8 (4.6%)
Glycemic status 0.024*
 High 14 (10.4%) 8 (20.5%) 22 (12.6%)
 Low 10 (7.4%) 9 (23.1%) 19 (10.9%)
 Normal 111 (82.2%) 22 (56.4%) 133 (76.4%)
CRP, mg/dL 27 (0–289) 77 (2–316) 47 (0–316) 0.015*
WBC (× 1000/mL) 12.9 (2.7–51) 11.5 (2.7–50) 12.6 (2.7–51) 0.32
Platelets (× 1000/mL) 162 (5–648) 40 (4–676) 141 (4–676) < 0.001*
Hemoglobin, g/dL 12.84 ± 3.11 11.73 ± 2.51 12.6 ± 3.01 0.042*
Creatinine, mg/dL 0.6 (0.2–2.7) 0.6 (0.16–1.2) 0.6 (0.16–2.7) 0.89
  1. Data is presented as number (percentage), mean ± standard deviation, or median (minimum–maximum)
  2. CRP C-reactive protein, WBC white blood cell count.
  3. *Statistically significant